Biotech Values

[genisi]

Just to note that Teva might have a stake there due to the Ivax acquisition:

http://www.tevapharm.com/pdf/12909ACL.PDF (see p.23)

"Ivax and Serono are parties to an agreement for the development of a proprietary oral formulation of cladribine (Mylinax®) as a treatment of multiple sclerosis."